Strategic Alliance in Indian Pharmaceutical Industry
Sri Sharada Institute Of Indian Management - Research
(A unit of Sri Sringeri Sharada Peetham, Sringeri)
Approved by AICTE
Plot No. 7, Phase-II, Institutional Area, Behind the Grand Hotel, Vasant Kunj,
New Delhi – 110070
Tel.: 2612409090 / 91; Fax: 26124092
E-mail: administration@srisim.org; Website: www.srisim.org
DEVELOPMENT DAY PROJECT REPORT
STRATEGIC ALLIANCE IN INDIAN PHARMACEUTICAL INDUSTRY
Submitted by: | Name: Jagriti Singh (20090123) Amardeep Tomar(20090106) Shilpa Jaiswal(20090155) Anil Chauhan(20090108) | Batch: | 2009 – 2011. |
MANAGING THROUGH WISDOM
INTRODUCTION
The competitive landscape of the Indian business firm has seen a dynamic change in the 1990s as a result of dual institutional changes of economic liberalization and changing intellectual policy regimes. Liberalization and its accompanying changes in trade, industry, foreign investment and technology policy regime, triggered previously protected Indian companies towards capability enhancement. This translated into a two pronged competitive strategy by the Indian firm - the adoption of a defensive strategy was aimed at protecting its competitive position in the domestic market and an assertive strategy aimed at leveraging new opportunities through internationalization. This paper examines the changing strategic orientations of the Indian Pharmaceutical industry through a study of its international venturing. It finds that firms have used acquisition as well as alliances in the spirit of co-opetition rather than competition, both in the domestic and international market as an important element of the industry’s survival strategy.
Introduction to Indian Pharmaceutical Industry
In the The Indian pharmaceutical industry has shown tremendous progress in terms of infrastructure development, technology base creation and a wide range of production. Even while undergoing restructuring, it has established its presence and
(A unit of Sri Sringeri Sharada Peetham, Sringeri)
Approved by AICTE
Plot No. 7, Phase-II, Institutional Area, Behind the Grand Hotel, Vasant Kunj,
New Delhi – 110070
Tel.: 2612409090 / 91; Fax: 26124092
E-mail: administration@srisim.org; Website: www.srisim.org
DEVELOPMENT DAY PROJECT REPORT
STRATEGIC ALLIANCE IN INDIAN PHARMACEUTICAL INDUSTRY
Submitted by: | Name: Jagriti Singh (20090123) Amardeep Tomar(20090106) Shilpa Jaiswal(20090155) Anil Chauhan(20090108) | Batch: | 2009 – 2011. |
MANAGING THROUGH WISDOM
INTRODUCTION
The competitive landscape of the Indian business firm has seen a dynamic change in the 1990s as a result of dual institutional changes of economic liberalization and changing intellectual policy regimes. Liberalization and its accompanying changes in trade, industry, foreign investment and technology policy regime, triggered previously protected Indian companies towards capability enhancement. This translated into a two pronged competitive strategy by the Indian firm - the adoption of a defensive strategy was aimed at protecting its competitive position in the domestic market and an assertive strategy aimed at leveraging new opportunities through internationalization. This paper examines the changing strategic orientations of the Indian Pharmaceutical industry through a study of its international venturing. It finds that firms have used acquisition as well as alliances in the spirit of co-opetition rather than competition, both in the domestic and international market as an important element of the industry’s survival strategy.
Introduction to Indian Pharmaceutical Industry
In the The Indian pharmaceutical industry has shown tremendous progress in terms of infrastructure development, technology base creation and a wide range of production. Even while undergoing restructuring, it has established its presence and